Jeanrenaud B
Experientia Suppl. 1983;44:57-76. doi: 10.1007/978-3-0348-6540-1_5.
Several types of experimental obesities are characterized by the occurrence of an early hypersecretion of insulin that produces an increase in both triglyceride secretion by the liver and fat deposition in adipose tissue. This hypersecretion of insulin, together with other ill-defined factors, is subsequently responsible for a state of insulin resistance. The early oversecretion of insulin in hypothalamic and genetic (e.g. fa/fa rats) obesities can be experimentally demonstrated. Thus, within 20 min of acute lesion of the ventromedial hypothalamus (VMH), glucose-induced insulin secretion is greater in lesioned than in non-lesioned control rats; this increase can be blocked by superimposed, acute vagotomy. Moreover, an infusion of glucose to 17-day-old, pre-weaned control and genetically pre-obese rats (i.e. animals genetically-determined to become obese but with a normal body weight at this age) elicits much greater insulinaemia in the pre-obese than in the controls, despite similar basal, pre-infusion values in both. This increased insulin secretion in the pre-obese rats can be restored to normal by pre-treating them acutely with the cholinergic inhibitor, atropine. Thus, in these two types of obesity, an increased vagal tone appears to be of importance for the early occurrence of insulin over-secretion. Hyperinsulinaemia produced by increased tone of the vagus nerve appears to be reinforced by the decreased activity of the sympathetic system observed in obese rodents. In many obese rodents, plasma growth hormone levels are abnormally low. The inadequate secretion of this hyperglycaemic hormone may explain why, in some types of obesity syndrome, hyperglycaemia is not necessarily present, despite insulin resistance. Insulin resistance in experimental obesities has been shown to occur at the level of the adipose tissue, the muscles and more recently, the liver. The latter has been demonstrated using the in vivo euglycaemic clamp technique; thus, glycogenolysis of genetically obese (fa/fa) rats could not be shut off, as in controls, by either basal or increased plasma insulin levels. This particular pathway is therefore insulin resistant. The precise etiology of the early over-secretion of insulin in VMH-lesioned rats is, however, unknown: with VMH lesions, the origin is clearly the central nervous system (CNS), but the pathways actually interrupted by the lesions and those responsible for the hyperactivity of the vagus, remain to be determined.(ABSTRACT TRUNCATED AT 400 WORDS)
几种类型的实验性肥胖的特征是早期胰岛素分泌过多,这会导致肝脏甘油三酯分泌增加以及脂肪组织中的脂肪沉积增加。这种胰岛素分泌过多,连同其他尚不明确的因素,随后会导致胰岛素抵抗状态。下丘脑性肥胖和遗传性肥胖(如fa/fa大鼠)中胰岛素的早期过度分泌可以通过实验证明。因此,在腹内侧下丘脑(VMH)急性损伤后20分钟内,损伤组大鼠由葡萄糖诱导的胰岛素分泌比未损伤的对照大鼠更多;这种增加可被叠加的急性迷走神经切断术阻断。此外,给17日龄、未断奶的对照大鼠和遗传性肥胖前期大鼠(即基因上注定会肥胖但在此年龄体重正常的动物)输注葡萄糖,尽管两组的基础输注前值相似,但肥胖前期大鼠的胰岛素血症比对照组高得多。通过用胆碱能抑制剂阿托品对肥胖前期大鼠进行急性预处理,可使其增加的胰岛素分泌恢复正常。因此,在这两种类型的肥胖中,迷走神经张力增加似乎对胰岛素早期过度分泌很重要。迷走神经张力增加所产生的高胰岛素血症似乎因在肥胖啮齿动物中观察到的交感神经系统活性降低而得到加强。在许多肥胖啮齿动物中,血浆生长激素水平异常低。这种升糖激素分泌不足可能解释了为什么在某些类型的肥胖综合征中,尽管存在胰岛素抵抗,但不一定会出现高血糖。实验性肥胖中的胰岛素抵抗已被证明发生在脂肪组织、肌肉以及最近发现的肝脏水平。后者已通过体内正常血糖钳夹技术得到证实;因此,与对照组不同,遗传性肥胖(fa/fa)大鼠的糖原分解不能被基础或升高的血浆胰岛素水平所抑制。因此,这条特定途径对胰岛素具有抗性。然而,VMH损伤大鼠中胰岛素早期过度分泌的确切病因尚不清楚:对于VMH损伤,其起源显然是中枢神经系统(CNS),但实际被损伤中断的途径以及导致迷走神经亢进的途径仍有待确定。(摘要截断于400字)